日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic

BET 抑制剂 BI 894999 的治疗效果:从临床回译

Ulrike Tontsch-Grunt, Paula-Elena Traexler, Anke Baum, Hanny Musa, Kristell Marzin, Shaonan Wang, Francesca Trapani, Harald Engelhardt, Flavio Solca

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations

无偏功能遗传学筛查可识别罕见的 ERBB4 激活突变

Deepankar Chakroborty #, Veera K Ojala #, Anna M Knittle, Jasmin Drexler, Mahlet Z Tamirat, Regina Ruzicka, Karin Bosch, Johanna Woertl, Susanne Schmittner, Laura L Elo, Mark S Johnson, Kari J Kurppa, Flavio Solca, Klaus Elenius

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

病例报告:阿法替尼治疗携带罕见 EGFR 外显子 20 突变的 NSCLC 患者

Sabine Zöchbauer-Müller, Bettina Kaserer, Helmut Prosch, Agnieszka Cseh, Flavio Solca, Markus Johann Bauer, Leonhard Müllauer

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

EGFR 和 SRC 联合治疗是治疗三阴性乳腺癌的潜在新方法

Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, Kevin P Fanning, Sandra Roche, Neil T Conlon, Fiona O'Neill, Justine Meiller, Mattia Cremona, Clare Morgan, Bryan T Hennessy, Alex J Eustace, Flavio Solca, Norma O'Donovan, John Crown

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)

EGFR 突变型非小细胞肺癌 (NSCLC) 中信号转导和转录激活因子 3 (STAT3) 信号的激活

Carles Codony-Servat, Jordi Codony-Servat, Niki Karachaliou, Miguel Angel Molina, Imane Chaib, Jose Luis Ramirez, Maria de Los Llanos Gil, Flavio Solca, Trever G Bivona, Rafael Rosell

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition

胰腺癌细胞对吉西他滨和 HER 抑制剂治疗的获得性耐药性伴随着对 STAT3 抑制的敏感性增加

Nikolaos Ioannou, Alan M Seddon, Angus Dalgleish, David Mackintosh, Flavio Solca, Helmout Modjtahedi

Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells

Hedgehog-EGFR协同反应基因决定基底细胞癌和肿瘤起始胰腺癌细胞的致癌表型

Markus Eberl, Stefan Klingler, Doris Mangelberger, Andrea Loipetzberger, Helene Damhofer, Kerstin Zoidl, Harald Schnidar, Hendrik Hache, Hans-Christian Bauer, Flavio Solca, Cornelia Hauser-Kronberger, Alexandre N Ermilov, Monique E Verhaegen, Christopher K Bichakjian, Andrzej A Dlugosz, Wilfried Nie

Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells

西妥昔单抗的获得性耐药性是由 PTEN 不稳定性增加介导的,并导致 HCC827 NSCLC 细胞对吉非替尼产生交叉耐药性

Sun Mi Kim, Ji Su Kim, Joo-Hang Kim, Chae-Ok Yun, Eun Mi Kim, Hyun Ki Kim, Flavio Solca, Soo-Young Choi, Byoung Chul Cho